Self-administration of gender-affirming hormones: a systematic review of effectiveness, cost, and values and preferences of end-users and health workers

被引:7
|
作者
Kennedy, Caitlin E. [1 ]
Yeh, Ping Teresa [1 ]
Byrne, Jack [2 ]
van der Merwe, L. Leigh Ann [3 ]
Ferguson, Laura [4 ]
Poteat, Tonia [5 ]
Narasimhan, Manjulaa [6 ]
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA
[2] Univ Waikato, Trans Hlth Res Lab, Aotearoa New Zealand Trans & Nonbinary Hlth Surve, Counting Ourselves, Hamilton, New Zealand
[3] Social Hlth & Empowerment Feminist Collect Transg, East London, South Africa
[4] Univ Southern Calif, Keck Sch Med, Inst Inequal Global Hlth, Los Angeles, CA 90007 USA
[5] Univ N Carolina, Sch Med, Dept Social Med, Chapel Hill, NC 27515 USA
[6] WHO, Dept Sexual & Reprod Hlth & Res, UNDP UNFPA UNICEF Who World Bank Special Programm, Geneva, Switzerland
关键词
gender-affirming hormone therapy; self-care; transgender health; self-administration; values and preferences; systematic review; TRANSGENDER PERSONS; CARE; BARRIERS; RISK;
D O I
10.1080/26410397.2022.2045066
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Self-administration of quality gender-affirming hormones is one approach to expanding access to hormone therapy for individuals seeking secondary sex characteristics more aligned with their gender identity or expression and can be empowering when provided within safe, supportive health systems. To inform World Health Organization guidelines on self-care interventions, we systematically reviewed the evidence for self-administration compared to health worker-administration of gender-affirming hormones. We conducted a comprehensive search for peer-reviewed articles and conference abstracts that addressed effectiveness, values and preferences, and cost considerations. Data were extracted in duplicate using standardised forms. Of 3792 unique references, five values and preferences articles were included; no studies met the criteria for the effectiveness or cost reviews. All values and preferences studies focused on self-administration of unprescribed hormones, not prescribed hormones within a supportive health system. Four studies from the U.S. (N = 2), Brazil (N = 1), and the U.K. (N = 1) found that individuals seeking gender-affirming hormone therapy may self-manage due to challenges finding knowledgeable and non-stigmatising health workers, lack of access to appropriate services, exclusion, and discomfort with health workers, cost, and desire for a faster transition. One study from Thailand found health worker perspectives were shaped by restrictive legislation, few transgender-specific services or guidelines, inappropriate communication with health workers, and medical knowledge gaps. There is limited literature on self-administration of gender-affirming hormone therapy. Principles of gender equality and human rights in the delivery of quality gender-affirming hormones are critical to expand access to this important intervention and reduce discrimination based on gender identity.
引用
下载
收藏
页数:17
相关论文
共 1 条
  • [1] Self-administration of gender-affirming hormones and supratherapeutic dosing are relatively common in Japanese transgender women
    Baba, Tsuyoshi
    Endo, Toshiaki
    Ikeda, Utako
    Ikeda, Hiroshi
    Ichihara, Koji
    Masumori, Naoya
    Saito, Tsuyoshi
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2022, 48 (08) : 2208 - 2213